FDA Not Satisfied With Philips Breathing Device Recall

South Africa News News

FDA Not Satisfied With Philips Breathing Device Recall
South Africa Latest News,South Africa Headlines
  • 📰 NEWSMAX
  • ⏱ Reading Time:
  • 8 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 7%
  • Publisher: 71%

The U.S. Food and Drug Administration (FDA) remains unsatisfied with the status of a product recall by healthcare technology company Philips , the regulator said in an update. Philips has recalled millions of sleep apnea and respiratory devices since 2021. In the update...

The U.S. Food and Drug Administration remains unsatisfied with the status of a product recall by healthcare technology company Philips , the regulator said in an update.In the update published overnight, the FDA said it believed Amsterdam-headquartered Philips should conduct additional testing on the risk posed to people who used recalled devices."This is negative news," analysts from Bernstein said in a note.

The long-running recall wiped out more than two-thirds of Philips' market valuation in 2021-2022, but it has staged a modest recovery in 2023.

We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

NEWSMAX /  🏆 16. in US

South Africa Latest News, South Africa Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

FDA Not Satisfied With Philips Breathing Device RecallThe U.S. Food and Drug Administration (FDA) remains unsatisfied with the status of a product recall by healthcare technology company Philips , the regulator said in an update. Philips has recalled millions of sleep apnea and respiratory devices since 2021. In the update...
Read more »

Philips shares dive as FDA calls for more testing on recalled devicesPhilips shares dive as FDA calls for more testing on recalled devicesSteven Goldstein is based in London and responsible for MarketWatch's coverage of financial markets in Europe, with a particular focus on global macro and commodities. Previously, he was Washington bureau chief, directing MarketWatch's economic, political and regulatory coverage. Follow Steve on Twitter: MKTWgoldstein.
Read more »

European stocks slightly higher as investors await U.S. payrolls data; Philips down 10%European stocks slightly higher as investors await U.S. payrolls data; Philips down 10%European stocks moved slightly higher on Friday as market participants brace themselves for U.S. jobs data later in the session.
Read more »

European stocks slightly higher as investors await U.S. payrolls data; Philips down 9%European stocks slightly higher as investors await U.S. payrolls data; Philips down 9%European stocks moved slightly higher on Friday as market participants brace themselves for U.S. jobs data later in the session.
Read more »

Philips shares fall 8% after U.S. drug regulator deals fresh blow to sleep device recallPhilips shares fall 8% after U.S. drug regulator deals fresh blow to sleep device recallShares of Dutch health tech company Philips fell on Friday after the U.S. drug regulator deemed its handling of a major product recall inadequate.
Read more »



Render Time: 2025-03-01 08:09:50